Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder.

IF 5.5 3区 医学 Q1 CLINICAL NEUROLOGY
Journal of Psychopharmacology Pub Date : 2025-07-01 Epub Date: 2025-06-28 DOI:10.1177/02698811251344687
Maggie M Sweitzer, Julianna Lazzari, Jessica Lunsford-Avery, Francis Joseph McClernon, Scott H Kollins, Kenneth A Perkins, Matthew Engelhard
{"title":"Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder.","authors":"Maggie M Sweitzer, Julianna Lazzari, Jessica Lunsford-Avery, Francis Joseph McClernon, Scott H Kollins, Kenneth A Perkins, Matthew Engelhard","doi":"10.1177/02698811251344687","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People with attention deficit hyperactivity disorder (ADHD) use nicotine products at higher rates than those without. Greater initial sensitivity to nicotine's cognitive effects may explain this association.</p><p><strong>Aims: </strong>This study examined associations between cognitive effects of nicotine administration and subsequent preference for nicotine versus placebo among young adults naïve to nicotine with and without ADHD.</p><p><strong>Methods: </strong>Participants (<i>n</i> = 61 ADHD, <i>n</i> = 75 Control) completed subjective (concentration, alertness) and objective (continuous performance task (CPT)) cognitive assessments in response to 3 doses of intranasal nicotine (0, 0.5, 1.0 mg; 1 dose per session). Choice to self-administer nicotine versus placebo (i.e., nicotine preference) was then assessed in two subsequent sessions under different task conditions-high cognitive demand and low demand. Analyses examined cognitive effects of nicotine dose and related those responses to nicotine preference under different task conditions.</p><p><strong>Results/outcomes: </strong>Nicotine increased subjective concentration and alertness for participants with ADHD but not controls; improved concentration predicted greater nicotine preference. In both groups, nicotine decreased errors of omission but increased errors of commission on the CPT, which predicted increased and decreased nicotine preference, respectively, during high cognitive demand. During the non-demanding condition, increased errors of commission predicted lower nicotine preference only for controls.</p><p><strong>Conclusions/interpretation: </strong>Perceived cognitive enhancement by nicotine may serve as a mechanism of risk for continued use in individuals with ADHD experimenting with nicotine. These findings help to clarify mechanisms underlying ADHD/nicotine use comorbidity and underscore the importance of early prevention.Declaration of interest/Funding:This work was supported by the National Institutes of Health.</p>","PeriodicalId":16892,"journal":{"name":"Journal of Psychopharmacology","volume":" ","pages":"694-702"},"PeriodicalIF":5.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12355662/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02698811251344687","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: People with attention deficit hyperactivity disorder (ADHD) use nicotine products at higher rates than those without. Greater initial sensitivity to nicotine's cognitive effects may explain this association.

Aims: This study examined associations between cognitive effects of nicotine administration and subsequent preference for nicotine versus placebo among young adults naïve to nicotine with and without ADHD.

Methods: Participants (n = 61 ADHD, n = 75 Control) completed subjective (concentration, alertness) and objective (continuous performance task (CPT)) cognitive assessments in response to 3 doses of intranasal nicotine (0, 0.5, 1.0 mg; 1 dose per session). Choice to self-administer nicotine versus placebo (i.e., nicotine preference) was then assessed in two subsequent sessions under different task conditions-high cognitive demand and low demand. Analyses examined cognitive effects of nicotine dose and related those responses to nicotine preference under different task conditions.

Results/outcomes: Nicotine increased subjective concentration and alertness for participants with ADHD but not controls; improved concentration predicted greater nicotine preference. In both groups, nicotine decreased errors of omission but increased errors of commission on the CPT, which predicted increased and decreased nicotine preference, respectively, during high cognitive demand. During the non-demanding condition, increased errors of commission predicted lower nicotine preference only for controls.

Conclusions/interpretation: Perceived cognitive enhancement by nicotine may serve as a mechanism of risk for continued use in individuals with ADHD experimenting with nicotine. These findings help to clarify mechanisms underlying ADHD/nicotine use comorbidity and underscore the importance of early prevention.Declaration of interest/Funding:This work was supported by the National Institutes of Health.

初始尼古丁暴露对有或无注意缺陷多动障碍的非吸烟青年认知和尼古丁强化的影响。
背景:患有注意缺陷多动障碍(ADHD)的人比没有ADHD的人使用尼古丁产品的比例更高。对尼古丁认知影响的更大的初始敏感性可能解释了这种联系。目的:本研究考察了年轻人对尼古丁的认知影响与尼古丁对安慰剂的偏好之间的关系naïve有或没有多动症的尼古丁。方法:对3种剂量的鼻内尼古丁(0、0.5、1.0 mg;每次1剂)。在随后的两个不同的任务条件下(高认知需求和低需求),对自我使用尼古丁和安慰剂的选择(即尼古丁偏好)进行了评估。分析了不同任务条件下尼古丁剂量对认知的影响及其与尼古丁偏好的关系。结果/结果:尼古丁增加了ADHD参与者的主观注意力和警觉性,但对照组没有;浓度的提高预示着更大的尼古丁偏好。在两组中,尼古丁减少了CPT的遗漏错误,但增加了CPT的委托错误,这分别预测了在高认知需求期间尼古丁偏好的增加和减少。在非要求条件下,任务误差的增加预示着只有对照组的尼古丁偏好降低。结论/解释:尼古丁感知到的认知增强可能是ADHD患者继续使用尼古丁的风险机制。这些发现有助于阐明ADHD/尼古丁使用合并症的潜在机制,并强调早期预防的重要性。兴趣/资助声明:这项工作由美国国立卫生研究院支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Psychopharmacology
Journal of Psychopharmacology 医学-精神病学
CiteScore
8.60
自引率
4.90%
发文量
126
审稿时长
3-8 weeks
期刊介绍: The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信